Diabetes Diagnostics in 2019: Global Market Analysis, Trends and Forecasts Through 2015-2022 - ResearchAndMarkets.com

DUBLIN--()--The "Diabetes Diagnostics: Global Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

This report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

The report analyzes the world market in US$ by the following Product Segments:

  • Continuous Glucose Monitoring (CGM) Systems
  • HbA1c Testing Devices
  • Blood Glucose Monitoring Devices

The report profiles 58 companies including many key and niche players such as:

  • A.Menarini Diagnostics Ltd. (UK)
  • Abbott Diabetes Care, Inc. (USA)
  • Acon Laboratories, Inc. (USA)
  • AgaMatrix, Inc. (USA)
  • Apex Biotechnology Corporation (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • B. Braun Melsungen AG (Germany)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • BIONIME Corporation (Taiwan)
  • Danaher Corporation (USA)
  • DexCom, Inc. (USA)
  • Diazyme Laboratories Inc. (USA)
  • EKF Diagnostics Holdings Plc (UK)
  • HemoCue AB (Sweden)
  • LifeScan, Inc. (USA)
  • Medtronic PLC (Ireland)
  • Nova Biomedical Corporation (USA)
  • OSANG Healthcare Co., Ltd. (South Korea)
  • PTS Diagnostics (USA)
  • Roche Diabetes Care, Inc. (USA)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Siemens Healthineers (Germany)
  • Sinocare, Inc. (China)
  • TaiDoc Technology Corporation (Taiwan)
  • Tandem Diabetes Care, Inc. (USA)
  • Terumo Corporation (Japan)
  • Tosoh Bioscience, Inc. (USA)
  • Trinity Biotech plc (Ireland)
  • Trividia Health, Inc. (USA)
  • Ypsomed AG (Switzerland)

Key Topics Covered

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

2. INDUSTRY OVERVIEW

Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic

Evolution of Diabetes Testing over the Years with Key Features in Each Period

Growth Drivers in a Nutshell

Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices

Diabetes Emerges as One of the Leading Causes of Death

Etiological Factors Causing Diabetes

Future Prospects Remain Favorable for Diabetes Diagnostics Market

Developed Regions Remain, Primary Revenue Contributors, Developing Countries Continue to Offer Significant Growth Opportunities

Key Factors Driving Sales of Diabetes Diagnostics in Developing Regions

Steep Increase in Number of Hospitals & Diagnostics Centers

Growing Healthcare Awareness & Parallel Increase in Consumer Healthcare Spending

Stable Economic Scenario to Underpin Market Expansion

3. MARKET TRENDS, DRIVERS & ISSUES

Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices

CGM Market Gradually Breaks through Barriers to Adoption

Intensive Care Units: A Highly Promising Market for CGMs

Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices

Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices

Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption

Home HbA1c Testing: An Overview

Glycated Albumin: A Potential Threat to HbA1c?

Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap

Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?

HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants

ESC and ADA Release Revised Guidelines for HbA1c Testing

Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales

Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems

Self-Monitoring

Household Blood Glucose: Sustaining Growth in Demand

Key Trends in the Glucose Meter/Monitoring Systems

Smartphone Penetration Favors SMBG Market

Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets

Barriers to Adoption of New Technology in BGM Products

Accuracy Issues Plague Blood Glucose Meters Market

Advancements in Glucose Monitoring Devices Offers a New Ray of Hope

Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential

Undiagnosed Diabetics: More Prone to Cardiovascular Diseases

Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices

Heart Disease

Stroke

High Blood Pressure

Blindness

Kidney Disease

Nerve Disease

Amputations

Dental Disease

Pregnancy

Microvascular Complications (Small Blood Vessel Damage)

Retinopathy

Diabetic Neuropathy

Nephropathy

Macrovascular Complications (Large Blood Vessel Damage)

Cardiac Problems

Hypertension (High Blood Pressure)

Infections

Impotence

Pregnancy Complications

Other Complications Resulting from Diabetes

Obesity

Obsessive-Compulsive Disorder

Foot Ulcers

Dementia

Hypoglycemia

Diabetic Ketoacidosis

Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications

High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion

Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential

Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis

Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market

Rising Expenditure on Diabetes Care Drives Diagnostic Devices Sales

Increasing Obesity Levels Underpins Market Growth

4. PRODUCT OVERVIEW

A Prelude

Continuous Glucose Monitoring (CGM) Systems

Hemoglobin A1c (HbA1c) Test

HbA1c Test Types

HbA1c Laboratory Testing

Analytical Techniques Used for Quantifying HbA1c in Labs

Standardization of HbA1c Results

HbA1c Point of Care Testing & Self-Monitoring

Blood Glucose Testing Devices

Blood Glucose Monitor/Meter

Diabetes Testing Supplies

Blood Glucose Test Strips

Lancet

Lancet Device

Reagent Strips

Reagent Tablet

Diabetes: A Chronic Body Disorder

Diabetes Symptoms

Types of Diabetes

Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)

Type II Diabetes: Non-Insulin-Dependent Diabetes Mellitus (NIDDM)

5. COMPETITIVE LANDSCAPE

Major Pharma Players Dominate Diabetes Diagnostics Market

Competition with Local Pharma Companies Intensifies in Regional Markets

Continuous Glucose Monitoring Systems (CGMS) Market

Medtronic Dominates the Global CGM Devices Market

Leading Companies Continue to Focus on CGM Innovations

Leading Companies and their CGM Innovations

Blood Glucose Monitoring (BGM) Devices Market

Quality Products at Low Prices: Mantra for Success in the Marketplace

After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move

Competition in the HbA1c Testing Devices Market

Select Laboratory-based HbA1c Testing Products/Analyzers

Select Point of Care HbA1c Testing Products/Analyzers

Major POC HbA1c Tests in the Market

Select HbA1c POC Tests in the Market - A Comparison

Product Innovation is the Name of the Game for HbA1c Testing Device Companies

Manufacturers Focus on Offering Products for Developing Markets

Innovations & Product Advancements: Prime Focus Area for Vendors

mHealth Solutions for Diabetes Diagnosis

Non-invasive Wearable Glucose Testing Devices

Apple and Google to Develop Wearable Continuous Glucose Monitors

GlySens Focus on Developing Implantable Continuous Glucose Monitor

Researchers Develop Prototype of Wearable Closed-Loop System

Glucovation SugarSenz: Cloud Enabled CGM Device

EyeSense to Develop Affordable CGM Device

Insulin Pump with CGM Sensor

Glucose Monitoring through Smartphone Apps: The Latest Breakthrough

Bar-Illan University of Israel's Research for Non-invasive, Wearable Glucose Testing Device

Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring

EMG 1000: Needle-free Device for Glucose Monitoring

Glucase: Smartphone Case with Glucose Testing Kit

Painless Diabetes Monitoring Using NFC Technology

GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels

ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes

Sugar.IQ App: Powerful Features for Diabetics

NoStrip Technology: Eliminating Need for Individual Test Strips

Artificial Pancreas System (APS): The Future of Diabetes Care

5.1 Focus on Select Global Players

5.2 Product Launches/Approvals

Medtronic Receives CE Mark for MiniMed 670G Hybrid Closed Loop System

Medtronic and IBM Watson Health Launch Sugar.IQ Smart Diabetes Assistant

Nova Biomedical Bags USFDA Approval for StatStrip Glucose Hospital Meter in Critically Ill Patient Care

Medtronic Bags USFDA Approval for New Arm Indication for Guardian Sensor 3 CGM System

Tandem Diabetes Care Bags CE Mark Approval for t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration

DexCom Receives CE Mark for DexCom G6 System

DexCom Receives US FDA Marketing Approval for Dexcom G6 CGM System

Abbott Introduces Afinion 2 Analyser in the US

Roche Diabetes Care Launches Accu-Chek Instant S Glucometer in India

Senseonics Launches Remote Monitoring Feature for Eversense CGM Systems in EMEA

DarioHealth Launches Retail Sales of Dario BGM System on Amazon Prime

Senseonics Receives CE Mark Approval for Eversense XL CGM System

Abbott Bags US FDA Approval for FreeStyle Libre as a Replacement for BGM

ARKRAY Introduces New Aluminum Foil Packaged BG Sensor for PocketChem BG PG-7320

U.S. ARKRAY Launches ADAMS A1c HA-8180V System for Hemoglobin A1c Testing

ARKRAY Releases ADAMS A1c HA-8190V Glycohemoglobin Analyzer

Bionime Launches GM700SB Bluetooth Glucose Meter in Taiwan

Abbott Bags Health Canada License for FreeStyle Libre Flash Glucose Monitoring System

Medtronic Unveils MiniMed 670G Hybrid Closed Loop Insulin Delivery System

HemoCue Launches HemoCue HbA1c 501 System in Thailand

Roche Introduces Accu-Chek Guide System and SimplePay Savings Program

One Drop Launches iOS-compatible One Drop Chrome BGM Kit

5.3 Recent Industry Activity

PTS Diagnostics to Move World Headquarters to Whitestown from Indianapolis

Siemens Healthineers Inks Comarketing Agreement with Hill-Rom

Tandem Inks Distribution Deals in Australia and New Zealand

Senseonics Inks Development Agreement with Beta Bionics

DexCom Inks Distribution Deal with Terumo in Japan

Innovation Zed Teams Up with GlucoRx

Tandem Diabetes Care Inks Distribution Agreement with Movi SpA in Italy

Platinum Equity to Acquire LifeScan

Tandem Submits License Application to Health Canada for t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration

Tandem Diabetes Care Inks Distribution Deal with Rubin Medical

Ascensia Diabetes Care Expands Scope of Strategic Alliance with Insulet

Tandem Diabetes Care Commences Full-Scale Operations at Newly Launched San Diego Facility

Infopia Becomes OSANG Healthcare

DexCom Collaborates with Eli Lilly and Company

Animas to Discontinue Animas Vibe and OneTouch Ping Insulin Pumps Business

Abbott Acquires Alere

Fitbit Teams Up with Dexcom for Diabetes Care

Roche and Accenture to Develop Core Data Platform for Digital Diabetes Ecosystem

Radisens Raises Additional Funding to Commercialize its Diabetes Management Platform

Abbott Teams Up with Bigfoot Biomedical

Ascensia Diabetes Care Joins Hands with DexCom

Roche to Acquire mySugr

Roche Inks Exclusive Partnership Deal with Medtronic

Asensia Diabetes Care Inks Global Technology Partnership Deal with Glooko

6. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 58 (including Divisions/Subsidiaries - 75)

  • The United States (35)
  • Canada (1)
  • Japan (4)
  • Europe (23)
    • France (2)
    • Germany (4)
    • The United Kingdom (8)
    • Italy (1)
    • Rest of Europe (8)
  • Asia-Pacific (Excluding Japan) (10)
  • Middle East (2)

For more information about this report visit https://www.researchandmarkets.com/r/7y6zh5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Endocrinology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Endocrinology